Open Access Open Badges Research article

Expenditure and resource utilisation for cervical screening in Australia

Jie-Bin Lew1, Kirsten Howard2, Dorota Gertig3, Megan Smith1, Mark Clements49, Carolyn Nickson15, Ju-Fang Shi16, Suzanne Dyer7, Sarah Lord27, Prudence Creighton110, Yoon-Jung Kang1, Jeffrey Tan8 and Karen Canfell16*

Author Affiliations

1 Cancer Research Division, Cancer Council NSW, 153 Dowling Street, Woolloomooloo, Sydney, NSW, 2011, Australia

2 Screening and Test Evaluation Program, School of Public Health, University of Sydney, Sydney, NSW, 2006, Australia

3 Victorian Cytology Service, 752 Swanston Street, Carlton, Melbourne, VIC, 3053, Australia

4 National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, 2000, Australia

5 Centre for Women’s Health, Gender and Society, University of Melbourne, 3/207 Bouverie Street, Carlton, Melbourne, 3053, Australia

6 School of Public Health, Sydney Medical School, University of Sydney, Sydney, NSW, 2006, Australia

7 NHMRC Clinical Trials Centre, University of Sydney, Locked bag 77, Camperdown, Sydney, NSW, 1450, Australia

8 Royal Women’s Hospital, Melbourne, Locked Bag 300, Grattan St & Flemington Rd, Parkville, Melbourne, VIC, 3052, Australia

9 Present address: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels väg 12 A, P.O. Box 281, SE-171 77, Stockholm, Sweden

10 Present address: School of Public Health and Community Medicine, University of NSW, Sydney, Australia

For all author emails, please log on.

BMC Health Services Research 2012, 12:446  doi:10.1186/1472-6963-12-446

Published: 5 December 2012

Additional files

Additional file 1:

Table S1. Average costs of medical consultation. Table S2. Problems managed per GP encounter – single service weighting. Table S3. Cost of screening test. Table S4. Cost of diagnostic procedures. Table S5. Cost of precancerous lesion treatment. Table S6. Cost post-treatment follow-up after CIN2/3 treatment. Table S7. Summary work-up and treatment by FIGO stage and disease extension. Table S8. Summary stage-specific cervical cancer work-up and treatment costs by FIGO stage. Table S9. Cost of surgical managements for cervical cancer treatment. Table S10. Cost of non-surgical managements.

Format: DOCX Size: 80KB Download file

Open Data